Clinical Trials

A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination with Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma Version Number: 1.3 Version Date: 09/24/2014


Study ID
UCSF 139511-MMRC

NCT Number
NCT02049138 (Click on the NCT number for more information about the trial)

Research Study Number
00005483

Principle Investigator
Dr. David Vesole

Phase
I

Sponsor
UCSF


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now